PMCB News and Press, PharmaCyte Biotech Inc. From 08/19/21

PharmaCyte Biotech, Inc. (NASDAQ: PMCB) (PharmaCyte or Company), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , today announced that it has entered into definitiv...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors continue to drive Virpax Pharmaceuticals (NASDAQ: VRPX ) stock higher on Wednesday after Tuesday’s major company news emerged. Source: Shutterstock The Pennsylvania-based firm said yesterday t...

Gainers: PharmaCyte Biotech (NASDAQ:PMCB) +118%. Virpax Pharmaceuticals (NASDAQ:VRPX) +59%. SGOCO Group (NASDAQ:SGOC) +53%. AzurRx BioPharma (NASDAQ:AZRX) +30%. NRx Pharmaceuticals (NASDAQ:NRXP) +26%. Standard Lithium (NYSE:SLI) +21%. ESSA Pharma (NASDAQ:EPIX) +15%. Agrify (NASDAQ:AGFY) +17%....

Nano cap stock PharmaCyte Biotech (PMCB +118.4%) has added over twofold in value intraday on above-average volume of shares. So far, ~142.9M PharmaCyte shares have changed hands, more than 33 times the average share volume over the past 65-day period. Last week, the company announce...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips ViacomCBS (NASDAQ: VIAC ) and Comcast (NASDAQ: CMCSA ) are teaming up to launch a new streaming service called SkyShowtime and VIAC stock is on the rise. Source: Jer123 / Shutterstock.com We’ve go...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tilray (NASDAQ: TLRY ) and MedMen (OTCMKTS: MMNFF ) are in the news Wednesday following the revelation that the former acquired a major stake in the latter. Source: Jetacom Autofocus / Shutterstock.com H...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips PharmaCyte Biotech (NASDAQ: PMCB ) stock is taking off on Wednesday and there are a few things that potential investors need to know about the company. Source: John Brueske/Shutterstock.com Let’s jump i...

Virpax Pharmaceuticals (NASDAQ:VRPX) +83%. PharmaCyte Biotech (NASDAQ:PMCB) +67%. BrainsWay Ltd BWAY +17% after FDA's Deep TMS system 510k clearance Novo Integrated Sciences (NASDAQ:NVOS) +14% subsidiary, acenzia, signs exclusive licensing agreement with performance inspired nu...

PharmaCyte Biotech, Inc. (NASDAQ: PMCB) (PharmaCyte or Company), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , today released a statement from Kenneth L. Waggone...

China Finance Online (NASDAQ:JRJC) -43% after receiving Nasdaq delisting notice and announces private placement of ordinary shares and warrants Sesen Bio (NASDAQ:SESN) -36% after FDA declines to approve Sesen Bio's Vicineum bladder cancer treatment Standard Lithium (N...